Cargando…
Feasibility and early toxicity of intraoperative radiotherapy for breast cancer using the papillon + system: First results
BACKGROUND AND PURPOSE: Breast intra operative radiation therapy has been evaluated with different systems delivering 20–21 Gy with treatment times around 30 min. Papillon + (TM) Contact X-ray machine was designed to produce a 50 kVp beam with a high dose rate ≥ 15 Gy/minute. A pilot study with the...
Autores principales: | Chand-Fouché, Marie-Eve, Colnard, Claudine, Gal, Jocelyn, Lam Cham Kee, Daniel, Dejean, Catherine, Gautier, Matthieu, Feuillade, Julien, Mana, Aurélia, Fouché, Yves, Delpech, Yann, Dejode, Magali, Gérard, Jean-Pierre, Barranger, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638720/ https://www.ncbi.nlm.nih.gov/pubmed/36353651 http://dx.doi.org/10.1016/j.ctro.2022.10.006 |
Ejemplares similares
-
Impact de la pandémie de COVID-19 sur les prises en charge pour cancer du sein et gynécologique
por: Gosset, Marie, et al.
Publicado: (2021) -
Concomitant cervical and transperineal parametrial high-dose-rate brachytherapy boost for locally advanced cervical cancer
por: Bailleux, Caroline, et al.
Publicado: (2016) -
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort
por: Marotte, Delphine, et al.
Publicado: (2022) -
Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2012) -
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
por: Hannoun-Levi, Jean-Michel, et al.
Publicado: (2022)